BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company ...
Earlier this month, major U.S. medical groups asked a federal judge to block the administration from implementing new guidance that cuts the number of vaccines routinely recommended for children and ...
The Centers for Disease Control and Prevention has issued updated guidance on who should receive the 2025 COVID-19 booster, focusing on people most at risk for severe illness. Under the current ...
The risk of a child dying from a COVID-19 vaccine is far lower than dying in a car accident. COVID-19 vaccines are effective in preventing hospitalizations, urgent care visits and long COVID in ...
The Federal Emergency Management Agency will release an additional nearly $166 million in public assistance funding for ...
The drug that ignited significant debate during the Covid pandemic is currently under examination as a possible treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results